Search

everythinglearnresearchcommunity

for

Search:↓

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Finasteride may cause kidney damage.

Chinese medicine may help hair growth and reduce hair loss in androgenetic alopecia.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

New tests detect finasteride and dutasteride in urine quickly and easily.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

Testosterone reduces heart damage and inflammation after injury.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

DHT stops hair regrowth in mice, similar to human hair loss.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.